Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537933) titled 'Intra-Arterial Tirofiban After Complete Recanalization for Acute Intracranial... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (NCT07537985) titled 'Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatini... Read More
Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260412001) titled 'The efficacy of Ursodeoxycholic Acid on Unconjugated Hyperbilirubinemia i... Read More
Tokyo, April 12 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061233) titled 'beta-trace protein concentrations in cerebrospinal fluid and epidural aspi... Read More
Singapore, April 11 -- The Health Sciences Authority received information related to the study titled ''Establishing the role of mitomycin C and systemic non-steroidal anti-inflammatory drugs in the p... Read More
Singapore, April 11 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-98650... Read More
Singapore, April 11 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemother... Read More
Singapore, April 11 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safe... Read More
Singapore, April 11 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) ... Read More
Singapore, April 11 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig ... Read More